[AP] – Sanofi-Aventis said Wednesday that hefty new restructuring costs caused its net profit to slump 64 percent in the fourth quarter, amid continued uncertainty over the fate of its nearly $20 billion bid for U.S. biotechnology firm Genzyme Corp.
Originally posted from Sanofi-Aventis net profit slumps on restructuring http://bit.ly/dSaT2y
No comments:
Post a Comment